Challenges to Laboratory Monitoring of Direct Oral Anticoagulants

Challenges to Laboratory Monitoring of Direct Oral Anticoagulants

Direct oral anticoagulants (DOACs) exert anticoagulation effect by directly inhibiting Factor Xa (rivaroxaban, apixaban, and edoxaban) or thrombin (dabigatran). Though DOACs are characterized by fixed-dose prescribing and generally do not require routine laboratory drug-level monitoring (DLM), circu...

Full description

Bibliographic Details
Main Authors: Jesse Qiao MD, Minh-Ha Tran DO
Format: Article
Language:English
Published: SAGE Publishing 2024-03-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296241241524

Internet

https://doi.org/10.1177/10760296241241524

Similar Items